Blocking the enzyme that breaks down 2-AG accelerated stress hormone recovery after restraint stress in mice, while blocking anandamide breakdown had no effect, and females showed compensatory mechanisms.
Read this if you want to understand how the endocannabinoid system regulates the stress response.
2-AG (via MAGL) drove stress recovery; anandamide (via FAAH) had no effect
What the researchers found
After restraint stress, mice lacking CB1 receptors or treated with a CB1 antagonist showed prolonged elevation of corticosterone (the stress hormone), confirming endocannabinoid signaling helps the stress response return to baseline.
The MAGL inhibitor JZL184 (which increases 2-AG levels) accelerated corticosterone recovery in both male and female mice, though the timing differed: at stress offset in males and at 30 minutes recovery in females. The FAAH inhibitor URB597 (which increases anandamide) had no effect on corticosterone in either sex.
Female CB1 receptor knockout mice showed compensatory mechanisms not seen in males: they had greater serum corticosterone binding capacity, and their stress hormone levels were normal at 30 minutes (unlike males) but elevated at 90 minutes. This suggests females undergo compensatory adaptations when CB1 signaling is absent from birth.
Why it matters
The endocannabinoid system plays a critical role in turning off the stress response. This study identifies 2-AG, rather than anandamide, as the primary endocannabinoid involved and reveals important sex differences in how this system regulates stress hormones. These findings are relevant to understanding stress-related disorders and potential endocannabinoid-based treatments.
The numbers in context
JZL184 reduced corticosterone at stress offset in males and at 30 min in females. URB597 had no effect in either sex. Male CB1 knockout mice had elevated corticosterone at 30 min. Female knockouts showed elevation at 90 min but not 30 min.
How the study worked
Male and female wild-type and CB1 receptor knockout mice were subjected to restraint stress. Blood samples were collected at multiple time points during recovery. Some mice were pre-treated with rimonabant (CB1 antagonist), JZL184 (MAGL inhibitor), or URB597 (FAAH inhibitor). Corticosterone levels were measured by immunoassay. Serum binding capacity was assessed in knockout mice.
What this study cannot tell us
This was a mouse study using pharmacological and genetic tools. The restraint stress model may not fully represent human stress experiences. Drug doses and timing were specific to the experimental protocol. Sex differences observed in knockout mice may reflect developmental compensation rather than acute sex-dependent mechanisms.
How to read the evidence
This is a preclinical animal study using pharmacological and genetic approaches. It provides mechanistic insight but requires human confirmation.
When this study was published
Published in 2014. Research on endocannabinoid-HPA axis interactions has continued with a focus on translational applications.
The bigger picture
Stress is a major factor in many psychiatric conditions, and the endocannabinoid system is increasingly recognized as a key regulator of the stress response. The finding that 2-AG, specifically, drives stress hormone recovery provides a more precise therapeutic target than general cannabinoid receptor activation.
Questions still open
- Could MAGL inhibitors serve as novel anxiolytics or stress-management drugs? Why does the timing of 2-AG's stress-buffering effect differ between males and females? Do these sex differences have implications for treating stress-related disorders in men versus women?
Common questions
What is the HPA axis?
Why does it matter whether 2-AG or anandamide is involved?
Read the original research
Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.
Pharmacology, biochemistry, and behavior, 117, 17-24
Citation
Roberts, Christopher J; Stuhr, Kara L; Hutz, Michael J; Raff, Hershel; Hillard, Cecilia J. (2014). Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.. Pharmacology, biochemistry, and behavior, 117, 17-24. https://doi.org/10.1016/j.pbb.2013.11.026
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)
- Why Does Weed Make You Paranoid? The Amygdala Connection